Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.

Worldwide, the prevalence of noncommunicable chronic diseases is increasing. The use of vaccines to induce autoantibodies that neutralize disease-related proteins offers a means to effectively and affordably treat such diseases. Twenty vaccines designed to induce therapeutic autoantibodies were clin...

Bibliografske podrobnosti
Main Authors:	Jennings, G, Bachmann, M
Format:	Journal article
Jezik:	English
Izdano:	2009

Podobne knjige/članki

Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
od: Link, A, et al.
Izdano: (2010)

Therapeutic vaccines for chronic diseases: successes and technical challenges.
od: Bachmann, M, et al.
Izdano: (2011)

A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
od: Tissot, A, et al.
Izdano: (2013)

RNA Phage VLP-Based Vaccine Platforms
od: David S. Peabody, et al.
Izdano: (2021-08-01)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
od: Spohn, G, et al.
Izdano: (2010)

VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
od: Aline Maria Vasconcelos Queiroz, et al.
Izdano: (2021-03-01)

Zika virus-like particle (VLP) based vaccine.
od: Hélène Boigard, et al.
Izdano: (2017-05-01)

DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines
od: Cabral-Miranda, G, et al.
Izdano: (2018)

Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
od: Braeden Donaldson, et al.
Izdano: (2017-08-01)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
od: Klimek, L, et al.
Izdano: (2018)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
od: Beck Markus, et al.
Izdano: (2010-07-01)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
od: Gustavo Cabral-Miranda, et al.
Izdano: (2018-11-01)

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma
od: Laura Scalambra, et al.
Izdano: (2025-01-01)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
od: Minna M. Hankaniemi, et al.
Izdano: (2020-08-01)

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
od: Louise Goksøyr, et al.
Izdano: (2022-12-01)

VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation
od: Seth M. Daly, et al.
Izdano: (2017-04-01)

Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes
od: Dominik A. Rothen, et al.
Izdano: (2024-08-01)

Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus
od: Saeed Mobini, et al.
Izdano: (2020-08-01)

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
od: Wasim A. Prates-Syed, et al.
Izdano: (2021-11-01)

An effectively protective VLP vaccine candidate for both genotypes of feline calicivirus
od: Yupeng Yang, et al.
Izdano: (2024-12-01)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
od: Joseph Torresi
Izdano: (2017-11-01)

A DNA inducing VLP vaccine designed for HIV and tested in mice.
od: Alexandre Calazans, et al.
Izdano: (2017-01-01)

Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?
od: Reeshu Gupta, et al.
Izdano: (2024-12-01)

A Novel Formulation Strategy to Deliver Combined DNA and VLP Based HPV Vaccine
od: Mohammad Nasir Uddin, et al.
Izdano: (2019-11-01)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
od: Lucie Jelínková, et al.
Izdano: (2023-01-01)

VLP 224 - VLP 322 TEATER TRADISI MELAYU II - MAKYONG SEPT-OKT 2000.
od: PPS, Pusat Pengajian Seni
Izdano: (2000)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
od: Bachmann, M
Izdano: (2005)

Study of the safety and immunogenicity of VLP-based vaccine for the prevention of rotavirus infection in neonatal minipig model
od: Ludmila V. Kostina, et al.
Izdano: (2023-11-01)

Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine
od: Ishizuka, A
Izdano: (2016)

VLP 112 - VLP 222 TEATER TRADISI MELAYU 1 - WAYANG KULIT SEPT-OKT 2000.
od: PPS, Pusat Pengajian Seni
Izdano: (2000)

Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
od: PLOS ONE Editors
Izdano: (2018-01-01)

A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection
od: Limin Yang, et al.
Izdano: (2022-01-01)

On the Optimisation of Illumination LEDs for VLP Systems
od: José Miguel Menéndez, et al.
Izdano: (2022-10-01)

VLP-based model for the study of airborne viral pathogens
od: Michael Caffrey, et al.
Izdano: (2024-06-01)

Single-Source VLCP System Based on Solar Cell Array Receiver and Right-Angled Tetrahedron Trilateration VLP (RATT-VLP) Algorithm
od: Dawei Xie, et al.
Izdano: (2024-06-01)

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
od: Erwan Atcheson, et al.
Izdano: (2021-04-01)

Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
od: Narendran Reguraman, et al.
Izdano: (2023-02-01)

Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
od: Anke M Mulder, et al.
Izdano: (2012-01-01)

Establishment of a yeast-based VLP platform for antigen presentation
od: David Wetzel, et al.
Izdano: (2018-02-01)

A universal plug-and-display vaccine carrier based on HBsAg VLP to maximize effective antibody response
od: Marini, A, et al.
Izdano: (2019)